News & Updates
Filter by Specialty:

OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
byAudrey Abella
In a retrospective review of real-world data from Japan, omidenepag isopropyl 0.002% ophthalmic solution (OMDI) demonstrated an intraocular pressure (IOP)-lowering effect in eyes with different types of glaucoma, without severe or serious adverse effects.
OMDI shows potential as first-line treatment for glaucoma in real-world trial
24 May 2022
Fewer hospitalizations with omicron vs delta suggest reduced severity of omicron variant
23 May 2022
byRoshini Claire Anthony
Infection with the omicron variant of SARS-CoV-2 was less likely to result in hospitalization than infection with the delta variant, according to an observational study from Denmark presented at ECCMID 2022 and published in The Lancet.
Fewer hospitalizations with omicron vs delta suggest reduced severity of omicron variant
23 May 2022
Intensive BP management reduces CVD deaths in overweight, obese patients
23 May 2022
byStephen Padilla
Intensive management of blood pressure (BP) leads to a significant reduction in cardiovascular events in overweight, obese I, and obese II patients without elevating safety risks, a study has shown.